Structure-Function Strategies to Improve the Pharmacological Value of Animal Toxins

Handbook of Biologically Active Peptides

Volumn , Issue , 2006, Pages 415-419

  Waard, Michel De ^a   Sabatier, Jean Marc ^b  

^a CEA GRENOBLE   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 38549150808     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369442-3/50062-3     Document Type: Chapter

References (24)

1. Alessandri-Haber N, Lecoq A, Gasparini S, Grangier-Macmath G, Jacquet G, Harvey AL, et al. Mapping the functional anatomy of BgK on Kv1.1, Kv1.2, and Kv1.3. Clues to design analogs with enhanced selectivity. J Biol Chem 1999, 274:35653-35661.
2. Beeton C, Pennington MW, Wulff H, Singh S, Nugent D, Crossley G, et al. Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases. Mol Pharmacol 2005, 67:1369-1381.
3. Blanc E, Sabatier JM, Kharrat R, Meunier S, El Ayeb M, Van Rietschoten J, et al. Solution structure of maurotoxin, a scorpion toxin from scorpio maurus, with high affinity for voltagegated potassium channels. Proteins 1997, 29:321-333.
4. Dauplais M, Lecoq A, Song J, Cotton J, Jamin N, Gilquin B, et al. On the convergent evolution of animal toxins. Conservation of a diad of functional residues in potassium channel-blocking toxins with unrelated structures. J Biol Chem 1997, 272:4302-4309.
5. de Haan EC, Wauben MH, Wagenaar-Hilbers JP, Grosfeld-Stulemeyer MC, Rijkers DT, Moret EE, et al. Stabilization of peptide guinea pig myelin basic protein 72-85 by N-terminal acetylation-Implications for immunological studies. Mol Immunol 2004, 40:943-948.
6. 2+ release efficacy of maurocalcine in skeletal muscle cells. J Biol Chem 2003, 278:37822-37831.
7. Estève E, Mabrouk K, Dupuis A, Smida-Rezgui S, Altafaj X, Grunwald D, et al. Transduction of the scorption toxin maurocalcine into cells-Evidence that the toxin crosses the plasma membrane. J Biol Chem 2005, 280:12833-12839.
8. 1H NMR structure, and activity of a three-disulfide-bridged maurotoxin analog designed to restore the consensus motif of scorpion toxins. J Biol Chem 2000, 275:13605-13612.
9. Fajloun Z, Mosbah A, Carlier E, Mansuelle P, Sandoz G, Fathallah M, et al. Maurotoxin Versus Pi1/HsTx1 toxins: Toward new insights in the understanding of their distinct disulfide bridge patterns. J Biol Chem 2000, 275:39394-39402.
10. Gazarian KG, Gazarian T, Hernández R, Possani LD Immunology of scorption toxins and perspectives for generation of antivenom vaccines. Vaccine 2005, 23:3357-3368.
11. Gilquin B, Racape J, Wrisch A, Visan V, Lecoq A, Grissmer S, et al. Structure of the BgK-Kv1.1 complex based on distance restrains identified by double mutant cycles. Molecular basis for convergent evolution of Kv1 channel blockers. J Biol Chem 2002, 277:37406-37413.
12. Huang CC, Stricher F, Martin L, Decker JM, Majeed S, Barthe P, et al. Scorpion-toxin mimics of CD4 in complex with human immunodeficiency virus gp120 crystal structures, molecular mimicry, and neutralization breadth. Structure 2005, 13:755-768.
13. Lindgren M, Hallbrink M, Prochiantz A, Langel U Cell-penetrating peptides. Trends Pharmacol Sci 2000, 21:99-103.
14. MacDonald GC, Glover N Effective tumor targeting: strategies for the delivery of armed antibodies. Curr Opin Drug Discov Devel 2005, 8:177-183.
15. M'Barek S, Chagot B, Andreotti N, Visan V, Mansuelle P, Grissmer S, et al. Increasing the molecular contacts between maurotoxin and Kvl.2 channel augments ligand affinity. Proteins 2005, 60:401-411.
16. + channels. J Biol Chem 2003, 278:31095-31104.
17. Mouhat S, Jouirou B, Mosbah A, De Waard M, Sabatier JM Diversity of folds in animal toxins acting on ion channels. Biochem J 2004, 378:717-726.
18. Mouhat S, De Waard M, Sabatier JM Contribution of the functional dyad of animal toxins acting on voltage-gated Kv1-type channels. J Pep Sci 2005, 11:65-68.
19. Regaya I, Beeton C, Ferrat G, Andreotti N, Darbon H, De Waard M, et al. Evidence for domain-specific recognition of SK and Kv channels by MTX and HsTx1 scorpion toxins. J Biol Chem 2004, 279:55690-55696.
20. + channels and scorpion toxins. Trends Pharmacol Sci 2003, 24:222-227.
21. +-channels. Toxicon 2004, 43:865-875.
22. Sabatier JM Chemical synthesis and characterization of small proteins: example of scorption toxins. Animal toxins 2000, 196-216. Birkhaüser Verlag, Basel, Switzerland. H. Rochat, M.F. Martin-Eauclaire (Eds.).
23. + channel, SKCa2. J Biol Chem 2001, 276:43145-43151.
24. Zenouaki I, Kharrat R, Sabatier JM, Devaux C, Karoui H, Van Reitschoten J, et al. In vivo protection against Androctonus australis hector scorption toxin and venom by immunization with a synthetic anlog of toxin II. Vaccine 1997, 15.